Israeli biotech comes into its own

Article Abstract:

Israeli scientists are among the most prolific inventors in the world, spawning a biotechnology industry that has grown to number 130 companies. Rebif, Copaxaone, Exelon and Doxil are the four best selling prescription medicines in 2005 that are products of Israeli innovation leading to the sales of $3.5 billion.

Author: Dichek, Bernard
Israel, Sales & consumption, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Biological products exc. diagnostic, Alzheimer Disease Controllers, Interferon, Innovations, Biotechnology industry, Biotechnology industries, Alzheimer's disease, Anti-Alzheimer's disease agents, Doxorubicin, Market size, Doxil (Medication), Exelon (Medication), Rebif (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Italy toasts Sardinia with SharDNA

Article Abstract:

Recently, the Sardinian geneticist Mario Pirastu announced the creation of Italy's first genomics company, SharDNA, which has been established to facilitate gene discovery among Sardinia's population.

Italy, Expanded capacity, plant expansion, DNA Probes, SharDNA

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Genentech's 2nd IPO

Article Abstract:

Genentech's second initial public offering raised about $2 billion when it sold 20 million shares at $97 each.

United States, Organizational history, Biological Products, Genentech Inc., GNE

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.